Feb 26, 2020 / 04:30PM GMT
Puneet Souda - SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Jim, the first question that I have here -- and let's talk a little bit about the quarter.
Questions and Answers:
Puneet Souda - SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research AnalystYou've traditionally grown about 10% to 12%. You maintained your guide there. Maybe just give us -- provide a bit of a backdrop of what happened in the quarter, onetime items. Are some of those things -- do you expect some of those to continue into the next couple of quarters here? And how should we think about the 10% to 12% for this year?
James T. Hippel - Bio-Techne Corporation - Senior VP of Finance & CFO
So yes, so Q2 was a lower quarter for us organic growth-wise and -- than what we've been accustomed to seeing. It was really -- a lot of it is driven out of Europe. Europe was -- it was down actually year-over-year for us, which has been double-digit
Trustpilot
